7 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... visualabstract #table #CVD
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... therapies" for HFrEF ... used in HFrEF: ... #CKD #HFrEF #management ... #pharmacology #cardiology
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
/follow‐up of iron ... , haemoglobin; HFrEF ... Management #Diagnosis #HFrEF ... #HeartFailure #Cardiology ... #Indications #Treatment
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... Algorithm #Management #Cardiology
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... ) Treatment - GDMT ... Ejection Fraction (HFrEF ... patients with HFrEF ... #HeartFailure #HFrEF
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Iron Deficiency ... functional ID) Treatment ... mortality and CV ... deficiency #CHF #HFrEF ... diagnosis #management #cardiology
HFpEF and CAD Management Algorithm
1. Consider revascularization based on current guidelines for CAD and HFpEF*
2. Statins:
HFpEF and CAD Management ... guidelines for CAD ... and HFpEF* 2. ... Enroll in HFpEF ... #CAD #Management